Search Results - "Mitsumatsu, Takako"
-
1
Clinical features of moyamoya disease with Graves’ disease: a retrospective study of 394,422 patients with thyroid disease
Published in Endocrine Journal (01-01-2023)“…Graves’ disease has been reported to affect the clinical features of moyamoya disease (MMD), an occlusion of the circle of Willis. This study aimed to clarify…”
Get full text
Journal Article -
2
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody—insight into the pathogenesis of autoimmune endocrinopathy
Published in Endocrine Journal (2019)“…Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer therapy, but…”
Get full text
Journal Article -
3
Establishment of reference intervals for fT3, fT4, and TSH levels in Japanese children and adolescents
Published in ENDOCRINE JOURNAL (01-01-2023)“…The present study aimed to establish new reference intervals (RIs) for serum free triiodothyronine (fT3), free thyroxine (fT4), and thyroid stimulating hormone…”
Get full text
Journal Article -
4
Prediction model of Graves’ disease in general clinical practice based on complete blood count and biochemistry profile
Published in ENDOCRINE JOURNAL (01-01-2022)“…Although untreated Graves’ disease (GD) is associated with a higher risk of cardiac complications and mortality, there is no well-established way to predict…”
Get full text
Journal Article -
5
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody - insight into the pathogenesis of autoimmune endocrinopathy
Published in ENDOCRINE JOURNAL (2019)“…Abstract. Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer…”
Get full text
Journal Article -
6
Large clinical studies on diabetic retinopathy
Published in Nihon rinshō (01-07-2012)Get more information
Journal Article -
7
Effect of GLP-1 receptor agonists on free fatty acids and implication for preventing atherosclerosis
Published in Atherosclerosis (01-08-2017)Get full text
Journal Article -
8
Mechanistic insights from sequential combination therapy with a sodium glucose co‐transporter‐2 inhibitor and a dipeptidyl peptidase‐4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin
Published in Diabetes, obesity & metabolism (01-02-2019)“…Aim To elucidate the mechanisms involved in the sequential use of SGLT2 and DPP4 inhibitors (SGLT2i and DPP‐4i). Methods Twenty‐six type‐2 diabetes mellitus…”
Get full text
Journal Article -
9
Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?
Published in Thyroid (New York, N.Y.) (01-09-2021)“…The prognosis of Graves' disease (GD) is reportedly related to sex, age, and genetic factors, although there is no consensus. The objective of this study was…”
Get more information
Journal Article -
10
d-ROMs and BAP as Potential Predictive Factors for New-Onset Diabetes
Published in Diabetes (New York, N.Y.) (01-07-2018)“…Background: Increased oxidative stress plays a role in the progression of atherosclerosis. Yet only few reports in NOD. Method: Derivatives of reactive oxygen…”
Get full text
Journal Article -
11
Extreme Hyperglycemia Causes Vascular Hypoperfusion at Optic Nerve Head in Diabetic Patients (DM)
Published in Diabetes (New York, N.Y.) (01-07-2018)“…Background: OCT angiography (OCTA) and laser speckle flowgraphy (LSFG) are novel and noninvasive imaging modalities which could evaluate fundus blood flow…”
Get full text
Journal Article -
12
The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease
Published in Thyroid (New York, N.Y.) (01-05-2022)“…Primary thyroid lymphoma (PTL) is known to develop mostly in patients with Hashimoto's thyroiditis (HT), and it is rare for it to develop in patients with…”
Get more information
Journal Article -
13
Clinical features of moyamoya disease with Graves’ disease: a retrospective study of 394,422 patients with thyroid disease
Published in Endocrine Journal (01-01-2023)“…Graves’ disease has been reported to affect the clinical features of moyamoya disease (MMD), an occlusion of the circle of Willis. This study aimed to clarify…”
Get full text
Journal Article -
14
Establishment of reference intervals for fT3, fT4, and TSH levels in Japanese children and adolescents
Published in Endocrine Journal (2023)“…The present study aimed to establish new reference intervals (RIs) for serum free triiodothyronine (fT3), free thyroxine (fT4), and thyroid stimulating hormone…”
Get full text
Journal Article -
15
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody—insight into the pathogenesis of autoimmune endocrinopathy
Published in Endocrine Journal (2019)“…Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer therapy, but…”
Get full text
Journal Article -
16
Prediction model of Graves’ disease in general clinical practice based on complete blood count and biochemistry profile
Published in Endocrine Journal (2022)“…Although untreated Graves’ disease (GD) is associated with a higher risk of cardiac complications and mortality, there is no well-established way to predict…”
Get full text
Journal Article -
17
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic
Published in Journal of the Endocrine Society (01-01-2022)“…Abstract Context The indirect effects of the COVID-19 pandemic on clinical practice have received great attention, but evidence regarding thyroid disease…”
Get full text
Journal Article -
18
Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves’ Disease Develop?
Published in Journal of the Endocrine Society (01-06-2021)“…Abstract Background Thyroid stimulating hormone receptor antibody (TRAb) is detected in the serum of patients with Graves’ disease (GD). This study aims to…”
Get full text
Journal Article -
19
Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution
Published in Journal of the Endocrine Society (01-03-2021)“…Abstract Context Medical treatment of Graves disease during the first trimester has been the subject of controversy ever since treatment with an antithyroid…”
Get full text
Journal Article -
20
The Potential Impact of the COVID-19 Pandemic on Clinical Management of Thyroid Disorders in Japan
Published in Journal of the Endocrine Society (03-05-2021)“…Background: The indirect influence of the coronavirus disease 2019 (COVID-19) pandemic on clinical practice has received great attention. However, the evidence…”
Get full text
Journal Article